MARKET WIRE NEWS

Overweight Recommendation Issued On CSTL By KeyBanc

Source: KlickAnalytics

2026-01-29 15:15:03 ET

  • KeyBanc analyst issues OVERWEIGHT recommendation for CSTL on January 29, 2026 08:40PM ET.
  • The previous analyst recommendation was Overweight.
  • CSTL was trading at $39.16 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 11 - Buy recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    < ...
    Full story available on KlickAnalytics.com
    Castle Biosciences Inc.

    NASDAQ: CSTL

    CSTL Trading

    4.34% G/L:

    $27.06 Last:

    95,175 Volume:

    $26.95 Open:

    mwn-link-x Ad 300

    CSTL Latest News

    February 26, 2026 06:03:41 pm
    Castle Biosciences (CSTL) Earnings Transcript

    CSTL Stock Data

    $948,047,644
    27,291,396
    0.3%
    60
    N/A
    Medical Diagnostics & Screening
    Healthcare
    US
    Friendswood

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App